21Vianet Group, Inc. to Announce Fourth Quarter and Full Year 2016 Financial Results
Feb 14, 2017 12:02 pm UTC| Business
BEIJING, Feb. 14, 2017 -- 21Vianet Group, Inc. (Nasdaq:VNET) (“21Vianet” or the “Company”), a leading carrier-neutral Internet data center services provider in China, today announced that it plans to release its fourth...
Feb 14, 2017 12:02 pm UTC| Business
NEW YORK, Feb. 14, 2017 -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, received Fast Track...
Feb 14, 2017 12:02 pm UTC| Business
NEW YORK, Feb. 14, 2017 -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, received Fast Track...
Feb 14, 2017 12:02 pm UTC| Business
NEW YORK, Feb. 14, 2017 -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, received Fast Track...
Cytori Provides Latest Corporate Update at the 2nd Annual Disruptive Growth & Healthcare Conference
Feb 14, 2017 12:01 pm UTC| Business
SAN DIEGO, Feb. 14, 2017 -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) announced today that it will present at the 2nd Annual Disruptive Growth Healthcare Conference at 11:15 AM Eastern Time (8:15 AM Pacific Time) on...
Cytori Provides Latest Corporate Update at the 2nd Annual Disruptive Growth & Healthcare Conference
Feb 14, 2017 12:01 pm UTC| Business
SAN DIEGO, Feb. 14, 2017 -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) announced today that it will present at the 2nd Annual Disruptive Growth Healthcare Conference at 11:15 AM Eastern Time (8:15 AM Pacific Time) on...
Ohr Pharmaceutical Announces Strategic Update and Fiscal First Quarter 2017 Earnings
Feb 14, 2017 12:01 pm UTC| Business
Management to Host a Conference Call and Webcast at 7:45a.m Eastern Time Today NEW YORK, Feb. 14, 2017 -- Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), a clinical-stage pharmaceutical company developing novel therapies for...